Singapore markets close in 3 hours 50 minutes

Biolidics Limited (8YY.SI)

SES - SES Delayed Price. Currency in SGD
Add to watchlist
0.02200.0000 (0.00%)
As of 05:04PM SGT. Market open.
Currency in SGD

Valuation measures4

Market cap (intra-day) 10.85M
Enterprise value 13.62M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)3.00
Price/book (mrq)N/A
Enterprise value/revenue 6.62
Enterprise value/EBITDA -3.88

Trading information

Stock price history

Beta (5Y monthly) 0.74
52-week change 3-86.67%
S&P500 52-week change 3-10.47%
52-week high 30.1840
52-week low 30.0210
50-day moving average 30.0251
200-day moving average 30.0536

Share statistics

Avg vol (3-month) 313.91M
Avg vol (10-day) 32.61M
Shares outstanding 5493.37M
Implied shares outstanding 6N/A
Float 8231.7M
% held by insiders 118.07%
% held by institutions 11.85%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)30 Sept 2022


Profit margin -225.69%
Operating margin (ttm)-218.70%

Management effectiveness

Return on assets (ttm)-32.32%
Return on equity (ttm)-674.95%

Income statement

Revenue (ttm)2.18M
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)-23.80%
Gross profit (ttm)498.12k
Net income avi to common (ttm)-4.92M
Diluted EPS (ttm)-0.0230
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)527k
Total cash per share (mrq)0
Total debt (mrq)3.29M
Total debt/equity (mrq)N/A
Current ratio (mrq)1.18
Book value per share (mrq)-0.00

Cash flow statement

Operating cash flow (ttm)-3.43M
Levered free cash flow (ttm)-2.21M